BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 10, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 13, 2001
View Archived Issues
NC-381 shows potential inhibitory effects on prostate tumor growth in preclinical studies
Read More
Early data from NHL patients treated with CpG-7909 indicate good safety, immunostimulatory effects
Read More
Potential of CP-461 in CLL supported by laboratory research discussed at ASH meeting
Read More
Valrocemide characterized as a safe, broad-spectrum anticonvulsant agent
Read More
Mechanism of anticonvulsant action of CGX-1007, an NMDA antagonist, explored
Read More
Retigabine appears not to interfere with low-dose oral contraceptives
Read More
Zonegran effective and safe as monotherapy in partial seizures
Read More
Repifermin continues to show excellent safety profile in phase II trials for various indications
Read More
Amsterdam Molecular Therapeutics receives grant for LPL gene therapy
Read More
Excellent safety, evidence of activity for beta-alethine in immunocompetent lymphoma patients
Read More
First phase III trial of AC-2993 for type 2 diabetes under way
Read More
Synsorb discontinues Synsorb-Cd development program
Read More
Initiation of second phase I trial of Triapine in advanced leukemia
Read More
Endovasc submits revised phase III protocol for Liprostin; requests FDA meeting
Read More
Microbiotix obtains exclusive worldwide license to novel antiviral compounds
Read More
Notice of allowance of patent for once-daily Cidecin dosing regimen
Read More
Wide series of macrocyclic compounds for HCV designed and disclosed in recent patent
Read More
CXCR1/CXCR2 receptor antagonists in the GSK pipeline
Read More
Definity launched in North American markets for contrast enhancement in echocardiography
Read More
Inhibitors of VEGF receptor tyrosine kinase and their use described by AstraZeneca
Read More
New piperidines described in patent literature act as NK1 receptor antagonists
Read More
Somatostatin sst2 receptor antagonists synthesized at Pfizer elevate GH secretion
Read More
Novartis presents potent new PDE5 inhibitors for erectile dysfunction
Read More
Tyrosine kinase inhibitors useful in cancer Rx designed at Boehringer Ingelheim
Read More
CPMP recommends approval of Dynepo for anemia of renal failure
Read More
